Supplementary Table S3 from Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on EnzalutamideWassim Abida,Andrew W. Hahn,Neal Shore, Neeraj Agarwal,Paul Sieber,Matthew R. Smith,Tanya Dorff,Paul Monk,Matthew Rettig,Rupal Patel,Anne Page,Maureen Duff,Rongda Xu,Jian Wang,Shravani Barkund,Aleksandr Pankov,Amber Wang,Melissa R. Junttila,Pratik S. Multani,Anneleen Daemen,Edna Chow Maneval,Christopher J. Logothetis,Michael J. Morriscrossref（2024）引用 0|浏览35暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
